Anzeige
Mehr »
Login
Dienstag, 12.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
417 Leser
Artikel bewerten:
(1)

Dongshan Investments announces intention to make A$1.20 cash takeover offer for Cardinal Resources

Finanznachrichten News

DUBAI, United Arab Emirates, Dec. 24, 2020 /PRNewswire/ -- Dongshan Investments Limited ("Dongshan") has today announced its intention to make an off-market takeover offer of A$1.20 per share ("Offer") to acquire all of the ordinary shares in Cardinal Resources Limited ACN 147 325 620 ("Cardinal").

Highlights

  • Intention to make an all-cash takeover offer of A$1.20.
  • Offer represents a 15% premium to the 3 (three) month Volume Weighted Average Price of 1.045A$ per Cardinal Share and a 12% premium to the maximum price offered under the current offer by Shandong (1.075A$ per Cardinal Share).
  • Conditions to the Offer will include financing, limited due diligence, and regulatory approvals (a full list of the conditions to the Offer is provided in Annexure 1 of this announcement).
  • Dongshan has a full cycle exploration and mining business in the Republic of the Sudan with production capacity of up to 95,000 ounces of gold per year (approx. 3 t Au/yr) which is supported by a strong in-house geological and production team with 10+ years' experience in exploration and mining (further information of Dongshan's technical experience is set out in Section 'About Dongshan' below).
  • Dongshan's Sudanese subsidiary, Alliance for Mining Co. Ltd., is the biggest industrial gold producer in Sudan.
  • Dongshan is aiming to enhance its gold production portfolio by acquiring world-class assets, and the Namdini Gold Project in Ghana, which is owned by the Cardinal Group (the "Namdini Project"), perfectly fits this development strategy.

Background to the Offer

In September 2020 Dongshan became an Emirati-Russian joint venture. Dongshan's shareholders tasked management with increasing Dongshan's resource base and bringing new exploration and mining projects to the group's portfolio. This is when the Namdini Project came to our attention as the first acquisition target. We believe that by acquiring the Namdini Project and later building it, we will establish ourselves as a major gold producer in West Africa.

Offer conditions

The Offer is subject to a number of conditions, including a limited due diligence condition and funding condition. A full list of the conditions to the Offer is provided in Annexure 1 of this announcement.

Dongshan requires that limited due diligence be undertaken to confirm circumstances listed in Annexure 2 of this announcement.

Dongshan is ready to commence due diligence immediately upon being granted access by Cardinal and intends to complete this process by 31 January 2021 at the latest.

Dongshan's majority shareholder, Wahaj Commercial Investment - Sole Proprietorship L.L.C. ("WAHAJ") has received confirmation from First Abu Dhabi Bank, U.A.E. of the availability of a credit facility of up to USD300,000,000 for the purposes of WAHAJ supporting the Offer, subject to First Abu Dhabi Bank's internal approvals and availability of limits.

About Dongshan

Dongshan is an Emirati-Russian joint venture that has been established by a common effort of Emirati and Russian business circles to develop high potential mining projects in different countries, especially countries in Africa.

Over the past 10 years, Dongshan has built a profound in-house exploration and mining expertise (mainly in Africa), enabling it to make independent verifications and geological evaluations for both internal and external clients and operate projects at all stages of their lifecycle from securing financing and exploration to marketing and monetization. The experience of the Dongshan team in mineral resources exploration covers countries as Sudan, Niger, Mali, Chad, Ivory Coast, Mauritania, Zimbabwe, and Eritrea.

Currently, Dongshan has an active gold production project in Sudan where it successfully proceeded from gold exploration to production stage with production capacity of up to 95,000 ounces of gold per year (approx. 3 t Au/yr). The main milestones which have been achieved in relation to this project are:

  • April 2013 - obtainment of exploration license for Block 30;
  • May 2015 - commenced gold production;
  • March 2016 - production of 1st ton of gold;
  • January 2018 - extension of production capacity of the gold processing plant to up to 3 t Au/y.

In addition, Dongshan currently has an active exploration project in the Islamic Republic of Mauritania.

Dongshan is aiming to increase its gold production portfolio with world-class assets, and the Namdini Project perfectly fits this development strategy.

Advisers

Dongshan has engaged the following advisers in relation to the Offer:

  • Financial advisor - PricewaterhouseCoopers Corporate Finance Inc. (Canada);
  • Legal and tax advisor - PricewaterhouseCoopers Legal (Australia);
  • Technical advisor - in-house geological and production team of Alnair Mineral Services DMCC (a wholly-owned subsidiary of Dongshan).

This release has been authorised by the Board of Directors of Dongshan.

PDF - https://mma.prnewswire.com/media/1391551/Appendix_document.pdf

© 2020 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.